Introduction to Seminars in Reproductive Medicine New Editors-in Chief

Kathleen M. Hoeger, MD, MPH

Terhi T. Piltonen, MD, PhD

Seminars in Reproductive Medicine was established 40 years ago in 1983 as Seminars in Reproductive Endocrinology. The name was changed in 2000 to represent the wider field of reproductive medicine. It is a peer-reviewed publication of invited in-depth reviews from experts in the field of reproductive medicine centered around relevant and timely clinical themes. The journal has a long history of distinguished editors with a wide breadth of experience in reproductive medicine. Professor Helena Teede most recently served as the journal's Editor-in Chief stepping down in December 2022. Her tenure saw the journal reach a wider audience with broad representation of topics in the field. In January 2023, the managing editors of Seminars in Reproductive Medicine appointed professors Kathleen Hoeger based in Rochester, NY, and Terhi Piltonen based in Oulu, Finland, as co-Editors-in-Chief for the newest iteration of the journal to capture perspectives of reproductive medicine from a broad world-wide perspective. Over the last several months we have worked to develop an editorial board that represents the diversity of the world experience in reproductive medicine and have begun to develop clinical topics for quarterly themed editions of the journal, which we believe are important to update the most relevant topics to the reproductive medicine community.

Professor Kathleen Hoeger, MD, MPH, is a reproductive endocrinologist who is Professor of Obstetrics and Gynecology and Chief of the Division of Reproductive Endocrinology at the University of Rochester, Rochester, NY. Dr. Hoeger completed her reproductive endocrinology training at the University of Virginia before taking a faculty position at the University of Rochester. She is an active clinician and clinical investigator in reproductive endocrinology for over 20 years. Her active clinical research is in polycystic ovary syndrome with emphasis on lifestyle modification impact, adolescent management of polycystic ovary syndrome (PCOS), and transgenerational impact on well-being and quality of life. Dr. Hoeger has been funded by the NIH/NICHD, a member of the Reproductive Medicine Network, Mae Stone Goode Foundation and Pharma. She is the founder and director of the PCOS Lifestyle Center at the University of Rochester, focusing on nutrition, lifestyle change, and medication in the management of PCOS. She has been involved in the development of the International Guidelines on the Diagnosis and Management of PCOS and the current update of the guidelines. She is a former president of the Androgen Excess and PCOS (AE-PCOS) Society and remains on the board. She also serves as an Editorial Board Member for Fertility and Sterility.

Professor Terhi Piltonen is a specialist in Obstetrics and Gynecology and Reproductive Endocrinology in the Department of Obstetrics and Gynecology, Clinical Research Unit, Oulu University Hospital, Finland. Dr. Piltonen did her postdoctoral training with Dr. Linda Giudice, Department of Obstetrics and Gynecology and Reproductive Medicine, UCSF, San Francisco, CA. In her postdoctoral studies, she investigated endometrial abnormalities in PCOS. She has published more than 130 peer-reviewed articles and several book chapters with a research interest focusing on lifelong-health risks in PCOS, endometrial health, and contraception. She has also dedicated her time in women's health awareness and common guideline development. Dr. Piltonen has been funded by the Academy of Finland, Novo Nordisk, Sigrid Jusélius Foundation, European Union and Pharma. Dr. Piltonen has been awarded as the Seth Wichman Young Scientists award and Unto Uotila Young Scientist award. Dr. Piltonen serves currently in the editorial board of European Journal of Endocrinology and is the president elect in the AE-PCOS Society and a board member and the chair of the Scientific Committee of the Nordic Federation of Societies in Obstetrics and Gynecology (NFOG).

Given the research interest and experience of the co-Editors-in-Chief, it is not surprising that we selected, as our first issue, issues relevant to the newly updated international guidelines in the diagnosis and management of PCOS. We are delighted to have this theme as the inaugural issue for the journal as new editors. As the most common disorder in reproductive medicine and the depth and degree of research that is being released daily with still a vast amount to be understood, PCOS is the topic relevant to all of the journal readers and likely encountered on a daily basis in practice. We hope this issue gives the reader new insights and inspires future research.

Our vision for the journal is to continue to provide a platform for a high-level review of relevant topics in reproductive medicine by experts in the field. We anticipate four issues per year and welcome input from the readership if there are topics that they would like to see reviewed. Our editorial board is composed of world experts from across the spectrum of reproductive medicine, representing a world-wide view. We hope the results of our endeavors are timely and helpful to the Reproductive Medicine Community.

Kathleen M. Hoeger, MD, MPH¹

Terhi T. Piltonen, MD, PhD²

Co-Editors-in-Chief

Publikationsverlauf

Artikel online veröffentlicht:
19. Dezember 2023